Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.33 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.33 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | PRCP | P42785 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.33 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.33 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.32 |
| ▸ | CTSL | P07711 | 1/20 | 0.32 |
| ▸ | CTSB | P07858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8510561 | 1.00 | ALDH1A1 (0.39) | ALDH1A1GRIN2DGRIN3BCYP2B6SLC6A2 | |
| SCHEMBL27003067 | 1.00 | ALDH1A1 (0.39) | ALDH1A1GRIN2DGRIN3BCYP2B6SLC6A2 | |
| SCHEMBL26039054 | 1.00 | ALDH1A1 (0.39) | ALDH1A1GRIN2DGRIN3BCYP2B6SLC6A2 | |
| SCHEMBL9853482 | 0.98 | ALDH1A1 (0.37) | ALDH1A1GRIN2DGRIN3BCYP2B6SLC6A2 | |
| Hydrochloric Acid SCHEMBL29587839 | 0.98 | ALDH1A1 (0.37) | ALDH1A1GRIN2DGRIN3BCYP2B6SLC6A2 | |
| SCHEMBL9853462 | 0.97 | ALDH1A1 (0.36) | ALDH1A1GRIN2DGRIN3BCYP2B6SLC6A2 | |
| SCHEMBL3237003 | 0.97 | ALDH1A1 (0.36) | ALDH1A1GRIN2DGRIN3BCYP2B6SLC6A2 | |
| Ethylene SCHEMBL9431984 | 0.95 | ALDH1A1 (0.36) | ALDH1A1GRIN2DGRIN3BCYP2B6SLC6A2 | |
| SCHEMBL9853465 | 0.95 | ALDH1A1 (0.35) | ALDH1A1CTSLCTSBCTSSCTSK | |
| SCHEMBL1347911 | 0.95 | ALDH1A1 (0.35) | ALDH1A1CTSLCTSBCTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 201 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200345723-A1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICAL INC (US) | 2020-11-05 | — | — | US | claimed |
| US-20200345722-A1 | ABUSE-DETERRENT DRUG FORMULATIONS | COLLEGIUM PHARMACEUTICAL INC (US) | 2020-11-05 | — | — | US | claimed |
| US-20200093820-A1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2020-03-26 | — | — | US | claimed |
| US-20200093819-A1 | ABUSE-DETERRENT DRUG FORMULATIONS | COLLEGIUM PHARMACEUTICAL, INC. | 2020-03-26 | — | — | US | claimed |
| EP-3326617-A1 | ABUSE-DETERRENT DRUG FORMULATIONS | Collegium Pharmaceutical, Inc. (US) | 2018-05-30 | — | — | EP | claimed |
| US-20180028529-A1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICAL, INC. | 2018-02-01 | — | — | US | claimed |
| US-20180028528-A1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICAL, INC. | 2018-02-01 | — | — | US | claimed |
| US-20170360710-A1 | ABUSE-DETERRENT DRUG FORMULATIONS | COLLEGIUM PHARMACEUTICAL, INC. | 2017-12-21 | — | — | US | claimed |
| US-20150265596-A1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICAL, INC | 2015-09-24 | — | — | US | claimed |
| US-9044398-B2 | Abuse-deterrent pharmaceutical compositions of opiods and other drugs | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2015-06-02 | — | — | US | claimed |
| US-20130045960-A1 | Abuse-Deterrent Pharmaceutical Compositions of Opiods and Other Drugs | COLLEGIUM PHARMACEUTICALS, INC. (US) | 2013-02-21 | — | — | US | claimed |
| US-20100260834-A1 | ABUSE-DETERRENT DRUG FORMULATIONS | COLLEGIUM PHARMACEUTICAL, INC. | 2010-10-14 | — | — | US | claimed |
| US-7771707-B2 | Abuse-deterrent drug formulations | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2010-08-10 | — | — | US | claimed |
| US-20090297617-A1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICALS INC. | 2009-12-03 | — | — | US | claimed |
| US-7399488-B2 | Abuse-deterrent pharmaceutical compositions of opiods and other drugs | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2008-07-15 | — | — | US | claimed |
| EP-1765292-A1 | ABUSE-DETERRENT DRUG FORMULATIONS | Collegium Pharmaceutical, Inc. (US) | 2007-03-28 | — | — | EP | claimed |
| WO-2005123039-A1 | ABUSE-DETERRENT DRUG FORMULATIONS | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2005-12-29 | — | — | WO | claimed |
| US-20050281748-A1 | Abuse-deterrent drug formulations | COLLEGIUM PHARMACEUTICAL, INC. | 2005-12-22 | — | — | US | claimed |
| US-20040052731-A1 | Abuse-deterrent pharmaceutical compositions of opiods and other drugs | COLLEGIUM PHARMACEUTICALS, INC. | 2004-03-18 | — | — | US | claimed |
| US-20260124141-A1 | TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICAL INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20250213554-A1 | PROCESS OF MAKING STABLE ABUSE-DETERRENT ORAL FORMULATIONS | TRUIST BANK, A NORTH CAROLINA CHARTERED BANK | 2025-07-03 | — | — | US | disclosed |
| US-20250082451-A1 | METHODS OF MAKING AN ORAL APPLIANCE | Emanate Biomedical, Inc. (US) | 2025-03-13 | — | — | US | disclosed |
| US-20250066085-A1 | CANNABINOID AND ALKALOID BEVERAGE CONTAINERS, AND ASSOCIATED DEVICES, SYSTEMS, AND METHODS | Green Sky Creations LLC (US) | 2025-02-27 | — | — | US | disclosed |
| WO-2024261775-A1 | A DRUG-ANTAGONIST COMBINATION DOSAGE FORM | PATEL JAYENDRAKUMAR DASHARATHLAL (IN) | 2024-12-26 | — | — | WO | disclosed |
| US-12156773-B2 | Methods of making an oral appliance | Emanate Biomedical, Inc. (US) | 2024-12-03 | — | — | US | disclosed |
| US-20240307164-A1 | ORAL APPLIANCE IN A BLOCKCHAIN SYSTEM | Emanate Biomedical, Inc. (US) | 2024-09-19 | — | — | US | disclosed |
| US-20240285554-A1 | POLYVINYL ALCOHOL COMPOSITIONS AND METHODS OF MAKING AND USING THEM | Emanate Biomedical, Inc. (US) | 2024-08-29 | — | — | US | disclosed |
| US-12006113-B2 | Cannabinoid and alkaloid beverage containers, and associated devices, systems, and methods | Green Sky Creations LLC (US) | 2024-06-11 | — | — | US | disclosed |
| US-11986368-B2 | Oral appliance in a blockchain system | Emanate Biomedical, Inc. (US) | 2024-05-21 | — | — | US | disclosed |
| CN-117980403-A | Transparent thermoplastic resin composition, molded article obtained therefrom, and method for producing transparent thermoplastic resin composition | 东丽株式会社 | 2024-05-03 | — | — | CN | disclosed |
| US-20240122920-A1 | PROCESS OF MAKING STABLE ABUSE-DETERRENT ORAL FORMULATIONS | COLLEGIUM PHARMACEUTICAL INC (US) | 2024-04-18 | — | — | US | disclosed |
| US-20230286710-A1 | CANNABINOID AND ALKALOID BEVERAGE CONTAINERS, AND ASSOCIATED DEVICES, SYSTEMS, AND METHODS | Green Sky Creations LLC (US) | 2023-09-14 | — | — | US | disclosed |
| US-20230037613-A1 | METHODS OF MAKING AN ORAL APPLIANCE | Emanate Blomedical, inc. (US) | 2023-02-09 | — | — | US | disclosed |
| US-11548703-B1 | Cannabinoid and alkaloid beverage containers, and associated devices, systems, and methods | Green Sky Creations LLC (US) | 2023-01-10 | — | — | US | disclosed |
| US-20220265410-A1 | AN ORAL APPLIANCE IN A BLOCKCHAIN SYSTEM | Emanate Biomedical, Inc. (US) | 2022-08-25 | — | — | US | disclosed |
| US-11273022-B2 | Oral appliance in a blockchain system | Emanate Biomedical, Inc. (US) | 2022-03-15 | — | — | US | disclosed |
| US-20210346385-A1 | TASTE-MASKED DOSAGE FORMS | DEEP OCEAN CAPITAL MANAGEMENT LP | 2021-11-11 | — | — | US | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-20210046014-A1 | PHARMACEUTICAL ABUSE DETERRENT COMPOSITION CONSTRUCTED IN MORE THAN ONE STRENGTHS | Patel, Jayendrakumar Dasharathlal (IN) | 2021-02-18 | — | — | US | disclosed |
| EP-3752096-A1 | METHODS OF MAKING AN ORAL APPLIANCE | Zegarelli, Peter, J. (US) | 2020-12-23 | — | — | EP | disclosed |
| US-20200368169-A1 | ABUSE-DETERRENT COMPOSITIONS | PATHEON SOFTGELS INC (US) | 2020-11-26 | — | — | US | disclosed |
| US-20200345723-A1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICAL INC (US) | 2020-11-05 | — | — | US | disclosed |
| US-20200345722-A1 | ABUSE-DETERRENT DRUG FORMULATIONS | COLLEGIUM PHARMACEUTICAL INC (US) | 2020-11-05 | — | — | US | disclosed |
| US-10772841-B2 | Opioid abuse-deterrent controlled release formulations | PATHEON SOFTGELS INC. (US) | 2020-09-15 | — | — | US | disclosed |
| US-10772842-B2 | Abuse-deterrent opioids | PATHEON SOFTGELS INC. (US) | 2020-09-15 | — | — | US | disclosed |
| CN-111521597-A | Method and kit for detecting fentanyl/morphine compound | 中国人民解放军军事科学院军事医学研究院 | 2020-08-11 | — | — | CN | disclosed |
| US-10668060-B2 | Tamper-resistant pharmaceutical compositions of opioids and other drugs | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2020-06-02 | — | — | US | disclosed |
| US-10646485-B2 | Process of making stable abuse-deterrent oral formulations | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2020-05-12 | — | — | US | disclosed |
| WO-2020061584-A1 | TASTE-MASKED DOSAGE FORMS | MSB HOLDINGS, INC. (US) | 2020-03-26 | — | — | WO | disclosed |
| US-20200093820-A1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2020-03-26 | — | — | US | disclosed |
| US-20200093819-A1 | ABUSE-DETERRENT DRUG FORMULATIONS | COLLEGIUM PHARMACEUTICAL, INC. | 2020-03-26 | — | — | US | disclosed |
| US-10478429-B2 | Abuse deterrent dosage forms | Patheon Softgels, Inc. (US) | 2019-11-19 | — | — | US | disclosed |
| US-20190262335-A1 | TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICAL, INC. | 2019-08-29 | — | — | US | disclosed |
| WO-2019160759-A1 | METHODS OF MAKING AN ORAL APPLIANCE | ZEGARELLI PETER JOHN (US) | 2019-08-22 | — | — | WO | disclosed |
| WO-2019160760-A1 | AN ORAL APPLIANCE IN A BLOCKCHAIN SYSTEM | ZEGARELLI PETER JOHN (US) | 2019-08-22 | — | — | WO | disclosed |
| US-20190255038-A1 | PROCESS OF MAKING STABLE ABUSE-DETERRENT ORAL FORMULATIONS | COLLEGIUM PHARMACEUTICAL, INC. | 2019-08-22 | — | — | US | disclosed |
| US-20190247174-A1 | ORAL APPLIANCE IN A BLOCKCHAIN SYSTEM | EMANATE BIOMEDICAL INC. | 2019-08-15 | — | — | US | disclosed |
| US-20190247173-A1 | METHODS OF MAKING AN ORAL APPLIANCE | EMANATE BIOMEDICAL INC. | 2019-08-15 | — | — | US | disclosed |
| US-10335405-B1 | Non-burst releasing pharmaceutical composition | Patheon Softgels, Inc. (US) | 2019-07-02 | — | — | US | disclosed |
| US-20190167662-A1 | TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICAL, INC. | 2019-06-06 | — | — | US | disclosed |
| WO-2019064082-A2 | PHARMACEUTICAL ABUSE DETERRENT COMPOSITION CONSTRUCTED IN MORE THAN ONE STRENGTHS | PATEL JAYENDRAKUMAR DASHARATHLAL (IN) | 2019-04-04 | — | — | WO | disclosed |
| US-10226432-B2 | Enteric soft capsule compositions | PATHEON SOFTGELS INC. (US) | 2019-03-12 | — | — | US | disclosed |
| US-20190054024-A1 | Solid Dosage Forms | HUMANWELL PHARMACEUTICAL US, Inc. (US) | 2019-02-21 | — | — | US | disclosed |
| US-10188644-B2 | Process of making stable abuse-deterrent oral formulations | COLLEGIUM PHARMACEUTICAL, INC (US) | 2019-01-29 | — | — | US | disclosed |
| US-10182992-B2 | Abuse-deterrent controlled release formulations | PATHEON SOFTGELS INC. (US) | 2019-01-22 | — | — | US | disclosed |
| US-20180369236-A1 | TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICAL, INC. | 2018-12-27 | — | — | US | disclosed |
| US-10105321-B2 | Pharmaceutical compositions resistant to abuse | EGALET LTD. (GB) | 2018-10-23 | — | — | US | disclosed |
| US-20180289697-A1 | PROCESS OF MAKING STABLE ABUSE-DETERRENT ORAL FORMULATIONS | COLLEGIUM PHARMACEUTICAL, INC. | 2018-10-11 | — | — | US | disclosed |
| US-10004729-B2 | Tamper-resistant pharmaceutical compositions of opioids and other drugs | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2018-06-26 | — | — | US | disclosed |
| EP-3326617-A1 | ABUSE-DETERRENT DRUG FORMULATIONS | Collegium Pharmaceutical, Inc. (US) | 2018-05-30 | — | — | EP | disclosed |
| US-9968598-B2 | Process of making stable abuse-deterrent oral formulations | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2018-05-15 | — | — | US | disclosed |
| US-9943513-B1 | Opioid abuse deterrent dosage forms | BANNER LIFE SCIENCES LLC (US) | 2018-04-17 | — | — | US | disclosed |
| US-20180071278-A1 | ANTI-OVERINGESTION DOSAGE FORMS | PATHEON SOFTGELS INC. | 2018-03-15 | — | — | US | disclosed |
| US-20180064817-A1 | Tamper Resistant Pharmaceutical Composition | Patel, Jayendrakumar Dasharathlal (IN) | 2018-03-08 | — | — | US | disclosed |
| US-20180055837-A1 | ABUSE DETERRENT DOSAGE FORMS | PATHEON SOFTGELS INC. | 2018-03-01 | — | — | US | disclosed |
| US-20180028529-A1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICAL, INC. | 2018-02-01 | — | — | US | disclosed |
| US-20180028528-A1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICAL, INC. | 2018-02-01 | — | — | US | disclosed |
| US-20180015046-A1 | ENTERIC SOFT CAPSULE COMPOSITIONS | PATHEON SOFTGELS INC (US) | 2018-01-18 | — | — | US | disclosed |
| US-9861629-B1 | Opioid abuse deterrent dosage forms | BANNER LIFE SCIENCES LLC (US) | 2018-01-09 | — | — | US | disclosed |
| WO-2017222575-A1 | PROCESS OF MAKING MORE STABLE ABUSE-DETERRENT ORAL FORMULATIONS | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2017-12-28 | — | — | WO | disclosed |
| US-20170368057-A1 | PROCESS OF MAKING STABLE ABUSE-DETERRENT ORAL FORMULATIONS | COLLEGIUM PHARMACEUTICAL, INC. | 2017-12-28 | — | — | US | disclosed |
| US-9849125-B1 | Anti-overingestion dosage forms | Banner Lifie Sciences LLC (US) | 2017-12-26 | — | — | US | disclosed |
| US-20170360710-A1 | ABUSE-DETERRENT DRUG FORMULATIONS | COLLEGIUM PHARMACEUTICAL, INC. | 2017-12-21 | — | — | US | disclosed |
| US-20170333354-A9 | ABUSE DETERRENT PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED RELEASE | EGALET LTD. (GB) | 2017-11-23 | — | — | US | disclosed |
| US-20170319575-A1 | TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICAL, INC. | 2017-11-09 | — | — | US | disclosed |
| US-20170312226-A1 | PHARMACEUTICAL DOSAGE FORMS | ASCENT PHARMA INC (US) | 2017-11-02 | — | — | US | disclosed |
| WO-2017189947-A1 | PHARMACEUTICAL DOSAGE FORMS | ASCENT PHARMACEUTICALS, INC. (US) | 2017-11-02 | — | — | WO | disclosed |
| WO-2017182861-A1 | TAMPER RESISTANT PHARMACEUTICAL COMPOSITION | PATEL JAYENDRAKUMAR DASHARATHLAL (IN) | 2017-10-26 | — | — | WO | disclosed |
| WO-2017184584-A1 | STABLE PACKAGING SYSTEM FOR MOISTURE AND OXYGEN SENSITIVE PHARMACEUTICAL DOSAGE FORMS | ASCENT PHARMACEUTICALS, INC. (US) | 2017-10-26 | — | — | WO | disclosed |
| US-20170304150-A1 | STABLE PACKAGING SYSTEM FOR MOISTURE AND OXYGEN SENSITIVE PHARMACEUTICAL DOSAGE FORMS | ASCENT PHARMA INC (US) | 2017-10-26 | — | — | US | disclosed |
| EP-1765292-B1 | ABUSE-DETERRENT DRUG FORMULATIONS | COLLEGIUM PHARMACEUTICAL INC (US) | 2017-10-04 | — | — | EP | disclosed |
| US-9775814-B2 | Enteric soft capsule compositions | PATHEON SOFTGELS INC. (US) | 2017-10-03 | — | — | US | disclosed |
| US-9763883-B2 | Abuse-deterrent drug formulations | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2017-09-19 | — | — | US | disclosed |
| US-9737530-B1 | Process of making stable abuse-deterrent oral formulations | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2017-08-22 | — | — | US | disclosed |
| US-20170181974-A1 | ABUSE DETERRENT PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED RELEASE | EGALET LTD. (GB) | 2017-06-29 | — | — | US | disclosed |
| US-20170182032-A1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICAL, INC. | 2017-06-29 | — | — | US | disclosed |
| EP-3184105-A1 | PHARMACEUTICAL COMPOSITIONS RESISTANT TO ABUSE | Egalet Ltd. (GB) | 2017-06-28 | — | — | EP | disclosed |
| US-9682075-B2 | Tamper-resistant pharmaceutical compositions of opioids and other drugs | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2017-06-20 | — | — | US | disclosed |
| US-20170157055-A1 | PHARMACEUTICAL ABUSE DETERRENT COMPOSITION | Patel, Jayendrakumar Dasharathlal (IN) | 2017-06-08 | — | — | US | disclosed |
| US-20170100341-A1 | PHARMACEUTICAL COMPOSITIONS RESISTANT TO ABUSE | EGALET LTD. (GB) | 2017-04-13 | — | — | US | disclosed |
| US-9592200-B2 | Abuse-deterrent pharmaceutical compositions of opioids and other drugs | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2017-03-14 | — | — | US | disclosed |
| US-9549899-B2 | Abuse deterrent pharmaceutical compositions for controlled release | EGALET LTD. (GB) | 2017-01-24 | — | — | US | disclosed |
| US-9498446-B2 | Pharmaceutical compositions resistant to abuse | EGALET LTD. (GB) | 2016-11-22 | — | — | US | disclosed |
| EP-2393487-B1 | PHARMACEUTICAL COMPOSITIONS RESISTANT TO ABUSE | EGALET LTD (GB) | 2016-11-02 | — | — | EP | disclosed |
| US-20160199368-A1 | ABUSE-DETERRENT OPIOIDS | PATHEON SOFTGELS INC. | 2016-07-14 | — | — | US | disclosed |
| WO-2016111731-A1 | ABUSE-DETERRENT OPIOIDS | BANNER LIFE SCIENCES LLC (US) | 2016-07-14 | — | — | WO | disclosed |
| US-9358295-B2 | Immediate release composition resistant to abuse by intake of alcohol | EGALET LTD. (GB) | 2016-06-07 | — | — | US | disclosed |
| WO-2016046842-A1 | PHARMACEUTICAL ABUSE DETERRENT COMPOSITION | PATEL JAYENDRAKUMAR DASHARATHLAL (IN) | 2016-03-31 | — | — | WO | disclosed |
| US-20160074332-A1 | PHARMACEUTICAL COMPOSITIONS RESISTANT TO ABUSE | EGALET LTD. (GB) | 2016-03-17 | — | — | US | disclosed |
| US-20160074326-A1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICAL, INC. | 2016-03-17 | — | — | US | disclosed |
| US-9248195-B2 | Abuse-deterrent pharmaceutical compositions of opioids and other drugs | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2016-02-02 | — | — | US | disclosed |
| US-20150366815-A1 | ENTERIC SOFT CAPSULE COMPOSITIONS | WXM LLC | 2015-12-24 | — | — | US | disclosed |
| WO-2015195989-A1 | ENTERIC SOFT CAPSULE COMPOSITIONS | BANNER LIFE SCIENCES LLC (US) | 2015-12-23 | — | — | WO | disclosed |
| US-20150313997-A1 | IMMEDIATE RELEASE COMPOSITION RESISTANT TO ABUSE BY INTAKE OF ALCOHOL | EGALET LTD. (GB) | 2015-11-05 | — | — | US | disclosed |
| US-9168228-B2 | Pharmaceutical compositions resistant to abuse | EGALET LTD. (GB) | 2015-10-27 | — | — | US | disclosed |
| WO-2015157150-A1 | OPIOID ABUSE-DETERRENT CONTROLLED RELEASE FORMULATIONS | BANNER LIFE SCIENCES LLC (US) | 2015-10-15 | — | — | WO | disclosed |
| WO-2015157138-A1 | ABUSE-DETERRENT CONTROLLED RELEASE FORMULATIONS | BANNER LIFE SCIENCES LLC (US) | 2015-10-15 | — | — | WO | disclosed |
| US-20150283087-A1 | ABUSE-DETERRENT CONTROLLED RELEASE FORMULATIONS | PATHEON SOFTGELS INC. | 2015-10-08 | — | — | US | disclosed |
| US-20150283088-A1 | OPIOID ABUSE-DETERRENT CONTROLLED RELEASE FORMULATIONS | PATHEON SOFTGELS INC. | 2015-10-08 | — | — | US | disclosed |
| US-20150152348-A1 | SYSTEMS AND METHODS FOR COLLECTING, TRANSPORTING AND REPURPOSING OR DESTROYING UNUSED PHARMACEUTICALS | SHARPS COMPLIANCE, INC. OF TEXAS | 2015-06-04 | — | — | US | disclosed |
| US-20150150812-A1 | CONTROLLED RELEASE FORMULATIONS WITH CONTINUOUS EFFICACY | EGALET LTD. (GB) | 2015-06-04 | — | — | US | disclosed |
| EP-2877161-A1 | ABUSE DETERRENT PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED RELEASE | Egalet Ltd. (GB) | 2015-06-03 | — | — | EP | disclosed |
| CN-104684548-A | Abuse deterrent pharmaceutical compositions for controlled release | EGALET LTD | 2015-06-03 | — | — | CN | disclosed |
| US-9044402-B2 | Abuse-deterrent pharmaceutical compositions for controlled release | EGALET LTD. (GB) | 2015-06-02 | — | — | US | disclosed |
| US-9044398-B2 | Abuse-deterrent pharmaceutical compositions of opiods and other drugs | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2015-06-02 | — | — | US | disclosed |
| US-9023394-B2 | Formulations and methods for the controlled release of active drug substances | EGALET LTD. (GB) | 2015-05-05 | — | — | US | disclosed |
| US-9005660-B2 | Immediate release composition resistant to abuse by intake of alcohol | EGALET LTD. (GB) | 2015-04-14 | — | — | US | disclosed |
| US-20150005332-A1 | TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICAL, INC. | 2015-01-01 | — | — | US | disclosed |
| US-20150004244-A1 | TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICAL, INC. | 2015-01-01 | — | — | US | disclosed |
| US-8840928-B2 | Tamper-resistant pharmaceutical compositions of opioids and other drugs | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2014-09-23 | — | — | US | disclosed |
| US-20140220126-A1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED RELEASE | EGALET LTD. (GB) | 2014-08-07 | — | — | US | disclosed |
| US-8758813-B2 | Abuse-deterrent drug formulations | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2014-06-24 | — | — | US | disclosed |
| US-20140121232-A1 | ABUSE-DETERRENT DRUG FORMULATIONS | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2014-05-01 | — | — | US | disclosed |
| EP-2700400-A1 | Controlled release formulation with continuous efficacy | Egalet Ltd. (GB) | 2014-02-26 | — | — | EP | disclosed |
| US-20140050787-A1 | PHARMACEUTICAL COMPOSITIONS RESISTANT TO ABUSE | EGALET LTD. (GB) | 2014-02-20 | — | — | US | disclosed |
| WO-2014006004-A1 | ABUSE DETERRENT PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED RELEASE | EGALET LTD. (GB) | 2014-01-09 | — | — | WO | disclosed |
| US-8603526-B2 | Pharmaceutical compositions resistant to abuse | EGALET LTD. (GB) | 2013-12-10 | — | — | US | disclosed |
| US-20130310413-A1 | ABUSE-DETERRENT DRUG FORMULATIONS | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2013-11-21 | — | — | US | disclosed |
| US-20130287849-A1 | FORMULATIONS AND METHODS FOR THE CONTROLLED RELEASE OF ACTIVE DRUG SUBSTANCES | ZYLA LIFE SCIENCES US INC., F/K/A EGALET US, INC. | 2013-10-31 | — | — | US | disclosed |
| US-20130287850-A1 | FORMULATIONS AND METHODS FOR THE CONTROLLED RELEASE OF ACTIVE DRUG SUBSTANCES | ZYLA LIFE SCIENCES US INC., F/K/A EGALET US, INC. | 2013-10-31 | — | — | US | disclosed |
| US-8563038-B2 | Formulations and methods for the controlled release of active drug substances | EGALET LTD. (GB) | 2013-10-22 | — | — | US | disclosed |
| US-8557291-B2 | Abuse-deterrent pharmaceutical compositions of opioids and other drugs | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2013-10-15 | — | — | US | disclosed |
| US-8449909-B2 | Abuse-deterrent drug formulations | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2013-05-28 | — | — | US | disclosed |
| US-20130045960-A1 | Abuse-Deterrent Pharmaceutical Compositions of Opiods and Other Drugs | COLLEGIUM PHARMACEUTICALS, INC. (US) | 2013-02-21 | — | — | US | disclosed |
| US-20120153138-A1 | METHODS FOR DETECTING SUBSTANCES IN BIOLOGICAL SAMPLES | eLab Consulting Services, Inc. | 2012-06-21 | — | — | US | disclosed |
| EP-2445487-A2 | CONTROLLED RELEASE FORMULATIONS | Egalet Ltd. (GB) | 2012-05-02 | — | — | EP | disclosed |
| EP-2389169-A1 | CONTROLLED RELEASE FORMULATIONS WITH CONTINUOUS EFFICACY | Egalet A/S (DK) | 2011-11-30 | — | — | EP | disclosed |
| US-8038094-B2 | Hydraulic system for aircraft | HONDA MOTOR CO., LTD. (JP) | 2011-10-18 | — | — | US | disclosed |
| US-20110159100-A1 | FORMULATIONS AND METHODS FOR THE CONTROLLED RELEASE OF ACTIVE DRUG SUBSTANCES | EGALET A/S (DK) | 2011-06-30 | — | — | US | disclosed |
| US-20110142943-A1 | TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIODS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2011-06-16 | — | — | US | disclosed |
| WO-2011066980-A2 | ORAL DOSAGE FORMS WITH REDUCED POTENTIAL FOR DRUG ABUSE | HERMANN LARS HOLGER (CH) | 2011-06-09 | — | — | WO | disclosed |
| WO-2010149169-A2 | CONTROLLED RELEASE FORMULATIONS | EGALET A/S (DK) | 2010-12-29 | — | — | WO | disclosed |
| US-20100291205-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MITIGATING RISK OF ALCOHOL INDUCED DOSE DUMPING OR DRUG ABUSE | EGALET A/S (DK) | 2010-11-18 | — | — | US | disclosed |
| US-20100260834-A1 | ABUSE-DETERRENT DRUG FORMULATIONS | COLLEGIUM PHARMACEUTICAL, INC. | 2010-10-14 | — | — | US | disclosed |
| US-20100203130-A1 | PHARMACEUTICAL COMPOSITIONS RESISTANT TO ABUSE | EGALET A/S (DK) | 2010-08-12 | — | — | US | disclosed |
| US-20100203129-A1 | CONTROLLED RELEASE FORMULATIONS WITH CONTINUOUS EFFICACY | EGALET A/S (DK) | 2010-08-12 | — | — | US | disclosed |
| US-20100204259-A1 | IMMEDIATE RELEASE COMPOSITION RESISTANT TO ABUSE BY INTAKE OF ALCOHOL | EGALET A/S (DK) | 2010-08-12 | — | — | US | disclosed |
| US-7771707-B2 | Abuse-deterrent drug formulations | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2010-08-10 | — | — | US | disclosed |
| WO-2010083843-A1 | CONTROLLED RELEASE FORMULATIONS WITH CONTINUOUS EFFICACY | EGALET A/S (DK) | 2010-07-29 | — | — | WO | disclosed |
| US-20100069726-A1 | COMPOSITIONS AND METHODS FOR RAPID ONE-STEP DIAGNOSIS | SEVENTH SENSE BIOSYSTEMS, INC. | 2010-03-18 | — | — | US | disclosed |
| US-20100047345-A1 | HYDROPHOBIC ABUSE DETERRENT DELIVERY SYSTEM FOR HYDROMORPHONE | CROWLEY MICHAEL M | 2010-02-25 | — | — | US | disclosed |
| US-7655256-B2 | Mixture of ion exchange resin and drug | ROHM AND HAAS COMPANY (US) | 2010-02-02 | — | — | US | disclosed |
| US-20090297617-A1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICALS INC. | 2009-12-03 | — | — | US | disclosed |
| EP-2104493-A2 | USE OF I) A POLYGLYCOL AND N) AN ACTIVE DRUG SUBSTANCE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR I) MITIGATING THE RISK OF ALCOHOL INDUCED DOSE DUMPING AND/OR II) REDUCING THE RISK OF DRUG ABUSE | Egalet A/S (DK) | 2009-09-30 | — | — | EP | disclosed |
| EP-2068840-A2 | HYDROPHOBIC ABUSE DETERRENT DELIVERY SYSTEM | LAB International SRL (US) | 2009-06-17 | — | — | EP | disclosed |
| EP-2049087-A2 | HYDROPHILIC ABUSE DETERRENT DELIVERY SYSTEM | LAB International SRL (US) | 2009-04-22 | — | — | EP | disclosed |
| EP-1594467-A4 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICAL INC (US) | 2008-10-22 | — | — | EP | disclosed |
| US-20080207601-A1 | Methods of and Compositions For the Prevention of Anxiety, Substance Abuse, and Dependence | HYTHIAM , INC. (US) | 2008-08-28 | — | — | US | disclosed |
| US-20080199530-A1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | COLLEGIUM PHARMACEUTICALS INC. | 2008-08-21 | — | — | US | disclosed |
| WO-2008086804-A2 | USE OF I) A POLYGLYCOL AND N) AN ACTIVE DRUG SUBSTANCE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR I) MITIGATING THE RISK OF ALCOHOL INDUCED DOSE DUMPING AND/OR II) REDUCING THE RISK OF DRUG ABUSE | EGALET A/S (DK) | 2008-07-24 | — | — | WO | disclosed |
| US-7399488-B2 | Abuse-deterrent pharmaceutical compositions of opiods and other drugs | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2008-07-15 | — | — | US | disclosed |
| US-20080075772-A1 | PHARMACEUTICAL COMPOSITIONS HAVING NOVEL SCORING PATTERNS AND METHODS OF USING THOSE COMPOSITIONS | ACCU-BREAK TECHNOLOGIES, INC. | 2008-03-27 | — | — | US | disclosed |
| US-20080075771-A1 | HYDROPHILIC OPIOID ABUSE DETERRENT DELIVERY SYSTEM USING OPIOID ANTAGONISTS | AKELA PHARMA SRL (BB) | 2008-03-27 | — | — | US | disclosed |
| US-20080075768-A1 | HYDROPHOBIC OPIOID ABUSE DETERRENT DELIVERY SYSTEM USING OPIOID ANTAGONISTS | AKELA PHARMA SRL (BB) | 2008-03-27 | — | — | US | disclosed |
| US-20080075770-A1 | HYDROPHILIC ABUSE DETERRENT DELIVERY SYSTEM | AKELA PHARMA SRL (BB) | 2008-03-27 | — | — | US | disclosed |
| US-20080069871-A1 | HYDROPHOBIC ABUSE DETERRENT DELIVERY SYSTEM | AKELA PHARMA SRL (BB) | 2008-03-20 | — | — | US | disclosed |
| WO-2008011595-A9 | HYDROPHOBIC ABUSE DETERRENT DELIVERY SYSTEM | LAB INTERNAT SRL (US) | 2008-03-06 | — | — | WO | disclosed |
| US-20080054008-A1 | Dispensing device | JAVELIN PHARMACEUTICALS, INC. (US) | 2008-03-06 | — | — | US | disclosed |
| WO-2008011595-A2 | HYDROPHOBIC ABUSE DETERRENT DELIVERY SYSTEM | LAB INTERNATIONAL SRL (US) | 2008-01-24 | — | — | WO | disclosed |
| US-20080017658-A1 | Dispensing device | JAVELIN PHARMACEUTICALS, INC. (US) | 2008-01-24 | — | — | US | disclosed |
| WO-2008011596-A2 | HYDROPHILIC ABUSE DETERRENT DELIVERY SYSTEM | LAB INTERNATIONAL SRL (US) | 2008-01-24 | — | — | WO | disclosed |
| US-20080020032-A1 | HYDROPHOBIC ABUSE DETERRENT DELIVERY SYSTEM FOR HYDROMORPHONE | AKELA PHARMA SRL (BB) | 2008-01-24 | — | — | US | disclosed |
| EP-1868593-A2 | IMPROVED METHODS OF AND COMPOSITIONS FOR THE PREVENTION OF ANXIETY, SUBSTANCE ABUSE, AND DEPENDENCE | Hythiam, Inc. (US) | 2007-12-26 | — | — | EP | disclosed |
| EP-1765292-A1 | ABUSE-DETERRENT DRUG FORMULATIONS | Collegium Pharmaceutical, Inc. (US) | 2007-03-28 | — | — | EP | disclosed |
| WO-2006110642-A2 | IMPROVED METHODS OF AND COMPOSITIONS FOR THE PREVENTION OF ANXIETY, SUBSTANCE ABUSE, AND DEPENDENCE | HYTHIAM, INC. (US) | 2006-10-19 | — | — | WO | disclosed |
| WO-2005123039-A1 | ABUSE-DETERRENT DRUG FORMULATIONS | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2005-12-29 | — | — | WO | disclosed |
| US-20050281748-A1 | Abuse-deterrent drug formulations | COLLEGIUM PHARMACEUTICAL, INC. | 2005-12-22 | — | — | US | disclosed |
| EP-1594467-A1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | Collegium Pharmaceutical, Inc. (US) | 2005-11-16 | — | — | EP | disclosed |
| US-20040126324-A1 | Pharmaceutical formulation including a resinate and an aversive agent | ROHM AND HAAS COMPANY | 2004-07-01 | — | — | US | disclosed |
| US-20040052731-A1 | Abuse-deterrent pharmaceutical compositions of opiods and other drugs | COLLEGIUM PHARMACEUTICALS, INC. | 2004-03-18 | — | — | US | disclosed |
| WO-2004004693-A1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIODS AND OTHER DRUGS | COLLGEGIUM PHARMACEUTICAL (US) | 2004-01-15 | — | — | WO | disclosed |
| US-20030068276-A1 | Dosage forms | ROHM AND HAAS COMPANY | 2003-04-10 | — | — | US | disclosed |
| US-20030059397-A1 | Solid oral dosage forms of controlled substances having reduced potential for abuse by inhalation, mastication, and injection; for alternative administration of oxycodone | HUGHES LYN (US) | 2003-03-27 | — | — | US | disclosed |
| EP-1293195-A1 | Oral pharmaceutical dosage forms with reduced potential for drug abuse, comprising respiratory irritants or bitter substances | ROHM AND HAAS COMPANY (US) | 2003-03-19 | — | — | EP | disclosed |
| EP-1293209-A1 | Oral pharmaceutical dosage forms with reduced potential for drug abuse | ROHM AND HAAS COMPANY (US) | 2003-03-19 | — | — | EP | disclosed |
| US-6342511-B1 | RACEMIC, ENANTIOMORPHS AND DIASTERIOMORPHS | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2002-01-29 | — | — | US | disclosed |
| EP-0986555-A1 | NOVEL PHENCYCLIDINE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2000-03-22 | — | — | EP | disclosed |
| WO-1998055478-A1 | NOVEL PHENCYCLIDINE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 1998-12-10 | — | — | WO | disclosed |
| US-5248686-A | Treatment of nervous depression | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 1993-09-28 | — | — | US | disclosed |
| US-4446065-A | CARBOXY OXIME OF 4-PHENYL-4-PIPERDINIOCYCLOHEXANONE | SYVA COMPANY (US) | 1984-05-01 | — | — | US | disclosed |
| US-4281065-A | Phencyclidine conjugates to antigenic proteins and enzymes | SYVA COMPANY (US) | 1981-07-28 | — | — | US | disclosed |
| US-4281065-A | Phencyclidine conjugates to antigenic proteins and enzymes | SYVA COMPANY (US) | 1981-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (17 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140220126-A1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED RELEASE | OPRK1, OPRM1, OPRL1 | ALDH1A1 403/4885GRIN2D 2187/4885GRIN3B 871/4885 |
| US-20140050787-A1 | PHARMACEUTICAL COMPOSITIONS RESISTANT TO ABUSE | OPRK1, CES2, OPRM1 | ALDH1A1 77/4885GRIN2D 1332/4885GRIN3B 864/4885 |
| US-20110159100-A1 | FORMULATIONS AND METHODS FOR THE CONTROLLED RELEASE OF ACTIVE DRUG SUBSTANCES | SLC18A1, CRH, NPSR1 | ALDH1A1 940/4885GRIN2D 1841/4885GRIN3B 1219/4885 |
| US-20150150812-A1 | CONTROLLED RELEASE FORMULATIONS WITH CONTINUOUS EFFICACY | ABCB11, CRH, LPXN | ALDH1A1 2699/4885GRIN2D 4387/4885GRIN3B 2711/4885 |
| US-20160074332-A1 | PHARMACEUTICAL COMPOSITIONS RESISTANT TO ABUSE | OPRK1, CES2, OPRM1 | ALDH1A1 77/4885GRIN2D 1332/4885GRIN3B 864/4885 |
| US-20100203130-A1 | PHARMACEUTICAL COMPOSITIONS RESISTANT TO ABUSE | OPRK1, CES2, OPRM1 | ALDH1A1 77/4885GRIN2D 1332/4885GRIN3B 864/4885 |
| US-20260124141-A1 | TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | OPRM1, OPRD1, OPRK1 | ALDH1A1 1066/4885GRIN2D 1714/4885GRIN3B 2130/4885 |
| US-20100204259-A1 | IMMEDIATE RELEASE COMPOSITION RESISTANT TO ABUSE BY INTAKE OF ALCOHOL | ADH1C, ADH1A, ADH5 | ALDH1A1 39/4885GRIN2D 2217/4885GRIN3B 1728/4885 |
| US-20100203129-A1 | CONTROLLED RELEASE FORMULATIONS WITH CONTINUOUS EFFICACY | ABCB11, CRH, LPXN | ALDH1A1 2699/4885GRIN2D 4387/4885GRIN3B 2711/4885 |
| US-20170181974-A1 | ABUSE DETERRENT PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED RELEASE | OPRK1, OPRM1, OPRL1 | ALDH1A1 340/4885GRIN2D 2284/4885GRIN3B 910/4885 |
| US-10105321-B2 | Pharmaceutical compositions resistant to abuse | OPRK1, CES2, OPRM1 | ALDH1A1 77/4885GRIN2D 1332/4885GRIN3B 864/4885 |
| US-20130287849-A1 | FORMULATIONS AND METHODS FOR THE CONTROLLED RELEASE OF ACTIVE DRUG SUBSTANCES | SLC18A1, CRH, NPSR1 | ALDH1A1 940/4885GRIN2D 1841/4885GRIN3B 1219/4885 |
| US-20170333354-A9 | ABUSE DETERRENT PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED RELEASE | OPRK1, OPRM1, OPRL1 | ALDH1A1 340/4885GRIN2D 2284/4885GRIN3B 910/4885 |
| US-20170100341-A1 | PHARMACEUTICAL COMPOSITIONS RESISTANT TO ABUSE | OPRK1, CES2, OPRM1 | ALDH1A1 77/4885GRIN2D 1332/4885GRIN3B 864/4885 |
| US-20100291205-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MITIGATING RISK OF ALCOHOL INDUCED DOSE DUMPING OR DRUG ABUSE | PYGL, PNLIP, ADH1C | ALDH1A1 234/4885GRIN2D 4325/4885GRIN3B 2989/4885 |
| US-20130287850-A1 | FORMULATIONS AND METHODS FOR THE CONTROLLED RELEASE OF ACTIVE DRUG SUBSTANCES | SLC18A1, CRH, NPSR1 | ALDH1A1 940/4885GRIN2D 1841/4885GRIN3B 1219/4885 |
| US-20150313997-A1 | IMMEDIATE RELEASE COMPOSITION RESISTANT TO ABUSE BY INTAKE OF ALCOHOL | ADH1C, ADH1A, ADH5 | ALDH1A1 39/4885GRIN2D 2217/4885GRIN3B 1728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.